learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Search
for
Did you mean Clinical Evaluation?
Learn
5 / 34 resultslearn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
learn sh-Polypeptide-7
learn Overview
learn Thymosin Beta 4
Research
5 / 1000+ resultsresearch Clinical Study of Patients with Female Pattern Hair Loss Over a 10-Year Period
Treating underlying metabolic and hormonal issues is key to managing female hair loss.
research Safety Profile and Efficacy of Biosea Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
Biosea® Revive Serum is safe and effective for improving hair growth and health.
research Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia
Micrografts improve hair density and thickness without side effects.
research Clinical and Macrophotographic Study of the Percutaneous Implantation of Synthetic Hair (Nido SHI)
Synthetic hair implants can be used to cover small bald spots.
research Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
The topical solution improved hair density and appearance in men with androgenetic alopecia.
Community Join
5 / 1000+ resultscommunity Did UCLA Just Cure Baldness? Check this Out!
UCLA's PP405 shows promise in reactivating dormant hair follicles for hair loss treatment but is still in clinical trials. Minoxidil and finasteride remain common treatments until PP405 becomes available.
community Life Extension - Hair Growth for Men
A new supplement for hair growth combines black rice, prickly pear, and saw palmetto, showing promising results in increasing hair density and reducing hair loss. The supplement is considered a drug-free alternative to traditional treatments like minoxidil and finasteride.
community Brief summary of new dutasteride study linked to infertility and the limitations/problems with the study
Dutasteride treatment may decrease sperm concentration, but levels remain above WHO recommendations and recover after discontinuation. The study has limitations, including small sample size and lack of pre-treatment sperm data, and does not assess other fertility factors.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.